Genbioma

Noáin, Spain · Founded 2019 · Privately Held (backing)

Developer of postbiotic therapeutics designed to support metabolic health in conditions related to glucose regulation, weight management, and cardiovascular function. Genbioma is based in Noáin, Spain and was founded in 2019. Its last reported valuation was $1.9 million in Jan 2021. It has raised $1.5 million.

Last reported valuation
$1.9M
Oct 2026
Priced at
—
Total raised
$1.5M
Last round
—

Who backs Genbioma?

8 investors
InvestorType
Clave (Pamplona)Venture capital
Sociedad de Desarrollo de NavarraOther
CaixaBank—
KMZERO (Valencia)—
Scale the Impact—
Socialnest—
UN I+D+i Technology Transfer fund—
WA4STEAM—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Genbioma investors

8 investors are on record for Genbioma, including Clave (Pamplona), Sociedad de Desarrollo de Navarra, CaixaBank and KMZERO (Valencia).

Free account
More of Genbioma with a free account
  • ·Watch Genbioma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Genbioma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View